Diabetic Retinopathy - Drug therapy
Research News and Information

Monday, November 23, 2009

Five-year results of a randomized trial with open-label extension of triamcinolone acetonide for refractory diabetic macular edema.

29 Sep 2009 OBJECTIVE: To report 5-year outcomes from a clinical trial of intravitreal triamcinolone acetonide (IVTA) in eyes with diabetic macular edema (DME) and impaired vision despite previous laser treatment. DESIGN: Prospective, double-masked, randomized ... Read more...

Visual acuity after intravitreal triamcinolone for diabetic macular edema refractory to laser treatment: a meta-analysis.

29 Sep 2009 OBJECTIVE: To quantify the effect on visual acuity of intravitreal triamcinolone for the treatment of laser-refractory diabetic macular edema (DME). STUDY DESIGN: Meta-analysis of eligible studies identified by searching MEDLINE, EMBASE, the ... Read more...

Intravitreal injection of bevacizumab before vitrectomy for proliferative diabetic retinopathy.

30 Aug 2009 PURPOSE: To evaluate the use of preoperative intravitreal bevacizumab (IVB) injection in patients undergoing pars plana vitrectomy for complications of proliferative diabetic retinopathy (PDR). METHODS: In this prospective surgeon-masked randomized ... Read more...

Latest indexed articles for 'Diabetic Retinopathy - Drug therapy'

These are the very latest articles for this heading:

• Bevacizumab local complications. 30 Oct 2009
• Five-year results of a randomized trial with open-label extension of triamcinolone acetonide for refractory diabetic macular edema. 29 Sep 2009
• Visual acuity after intravitreal triamcinolone for diabetic macular edema refractory to laser treatment: a meta-analysis. 29 Sep 2009
• Intravitreal injection of bevacizumab before vitrectomy for proliferative diabetic retinopathy. 30 Aug 2009
• Diabetic macular edema. 30 Aug 2009
• Monitoring ocular drug therapy by analysis of aqueous samples. 20 Aug 2009
• Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in diabetes (READ-2) study. 20 Aug 2009
• Intravitreal pegaptanib sodium (Macugen) for diabetic macular oedema. 10 Aug 2009
• Intravitreal steroid versus macular laser for treatment of diabetic macular edema. 30 Jul 2009
• Intravitreal plasmin without associated vitrectomy as a treatment for refractory diabetic macular edema. 30 Jul 2009
• Factors associated with variability in response of diabetic macular oedema after intravitreal triamcinolone. 30 Jul 2009
• Anterior staphyloma following an intravitreal injection of triamcinolone for the treatment of diabetic macular edema. 30 Jul 2009
• [Efficacy and safety of etofibrate in patients with non-proliferative diabetic retinopathy] 28 Jul 2009
• Primary intravitreal bevacizumab for diffuse diabetic macular edema: the Pan-American Collaborative Retina Study Group at 24 months. 7 Jul 2009
• Is intravitreal bevacizumab treatment effective in diffuse diabetic macular edema? 5 Jul 2009
• Primary prevention using losartan in type 1 diabetic patients significantly reduces retinopathy. 29 Jun 2009
• (Pro)renin receptor: a treatment target for diabetic retinopathy? 29 Jun 2009
• Dose dependent effects of intravitreal triamcinolone acetonide on diffuse diabetic macular edema. 7 Jun 2009
• [Vitamins for the eyes? Risks and opportunities for physician and patient] 30 May 2009
• Correspondence. 30 May 2009

See a longer list of these articles.

Technical information about 'Diabetic Retinopathy'

Definition: Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.

Descriptor UI: D003930

Alternative terms: Diabetic Retinopathy; Diabetic Retinopathies; Retinopathies, Diabetic; Retinopathy, Diabetic;

Allowable Qualifiers: blood; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; surgery; therapy; urine; veterinary; ultrasonography; virology;

Tree Number: C11.768.257; C14.907.320.382; C19.246.099.500.382;

Technical Notes: coordinate IM with specific type of diabetes mellitus (IM) if pertinent